Karnataka polls: With assets over Rs 1,020-cr Priya Krishna is the richest candidate

Kasaragod, Jul 26: First funeral, now wedding. Forty-three persons who attended a wedding at Pilankatta in Chengala panchayat in Kasaragod on July 17 have tested positive for Covid-19, said district medical officer (DMO) A V Ramdas.

They include the bride and the groom. Collector D Sajith Babu has asked all those who attended the wedding to go into home quarantine for 14 days. Those with Covid symptoms should get in touch with the nearest primary health centre, he said.

The DMO said samples of 128 persons linked to the wedding were tested, of which 43 turned out positive. Earlier, 44 persons who attended a funeral in Cherkala in the first week of July had tested positive. The funeral was declared a cluster and the government had to test 522 persons linked to the funeral.

The collector said those taking part in funeral or weddings without following the Covid protocol would be booked under the Kerala Epidemic Diseases Act. If convicted, they would face up to two years of rigorous imprisonment and a fine of `10,000. Kasaragod police said they will register a case in connection with the wedding. 

Pilankatta ward member Abdulla Kunhi K B said it was not a big fat wedding. The ceremony held at the bride’s house at Pilankatta was attended by less than 100 people, he said.“Theirs is a big family with four houses in one compound. 

As many as 30 members are staying in these houses,” said Kunhi. Nine of the 30 have tested positive.Of the 15 guests, who came from the bride’s mother’s house, 12 contracted the infection. “The rest of the infected persons were among the groom’s guests,” said Kunhi, who did not attend the wedding. The groom and the bride’s father returned from Dubai three months ago.

1,049: state records biggest recovery
A total of 1,049 Covid patients recovered on Saturday. This is the first time that the number of recoveries crossed the 1,000-mark in the state. The previous highest was 968 reported on Friday. So far, as many as 8,613 patients have recovered.

roping in ayush experts a challenge  
Plan to bring AYUSH practitioners for treating positive patients at CFLTCs is going to be a challenge for the government. It turned out that respective associations were planning to approach the government with an individual charter of demands. 

Bengaluru, July 20: The Karnataka government has reiterated that no final decision has so far been taken on reopening of schools in the state.

The clarification comes after minutes of the July 15 HRD ministry meeting where Karnataka education department officials said schools are reopening on September 1 went viral on social media. 

“The state government has not decided yet on starting schools. That they will reopen in September was only a general opinion expressed by our officials at the meeting. At present, we have no plans to start schools unless there is a conducive environment. There’s no need for anxiety,” said primary and secondary minister S Suresh Kumar.

Kumar said the government is involved in meeting the education sector’s changed priorities in the current scenario.

The minutes were of a virtual conference on school-safety plans, with representatives of state governments and Union territories expressing views on reopening of schools. 

Against the name of Karnataka, “After September 1” was written. Similar datelines were given by Kerala, Ladakh, Manipur, Rajasthan, Odisha and Andhra Pradesh, while in case of many other states it said “no decision”.

An education department official said Karnataka submitted to MHRD that it will be able to take a decision only after September 1, depending on the situation in the state.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.